Accelerating development. Navigating complexity. Reaching global markets
Adjutor provides integrated clinical, regulatory, quality and commercialisation services for medicines, biologics, advanced therapies and medical devices.
Our experienced team works alongside yours to develop practical global strategies, execute complex programs and help you reach patients and markets efficiently.
Why Choose Us?
The Adjutor Advantage
We see the whole pathway, not just the next step. By connecting strategy, development, clinical, regulatory, quality and commercialisation expertise, we help you make better decisions today that support where your product needs to be tomorrow.
★★★★★
Excellent quality, timeliness and responsiveness. Polite and helpful. Really felt like one team.
EU Based Biopharmaceutical Company
★★★★★
Our partnership and collaboration with the Adjutor Healthcare team has been phenomenal and has contributed to our successes in Australia, Singapore, and South Korea.
USA Based Biopharmaceutical Company
★★★★★
The consultants are “very knowledgeable, proactive collaborative and excellent communicators.
USA Based Biopharmaceutical Company
★★★★★
My experience over the last couple of years has been very positive and I can’t think of any areas of improvement.
USA Based Biopharmaceutical Company
★★★★★
Very collaborative teams who asked intelligent questions and thought ahead.
EU Based Biopharmaceutical Company
★★★★★
The consultants I work with at Adjutor are “just amazing, responding very quickly, very organised, highly knowledge” … with projects “delivered on time and with high quality standards.
USA Based Biopharmaceutical Company
Our Responsiveness
Quick to respond with an appreciation of your commercial drivers.
Our Drive & Agility
Our exceptional drive and agility allows us to expedite your projects.
Our Flexibility
Understanding and adapting to your evolving needs.
Our Experience & Expertise
Our team has extensive industry experience and are multi-skilled.
Our Collaboration
We work seamlessly as an extension of your team.
Our Reliability & Quality
Effectively delivering high quality services.
Development, Regulatory & Commercialisation Services
Regulatory Affairs and Market Access
Turning regulatory complexity into a clear path to market.
Sponsorship and Commercialisation
Opening new markets and creating the right strategy for commercial success.
Quality and Training
Practical, fit-for-purpose quality systems that support compliance, capability and growth.
Strategy and Project Management
Accelerating development. Navigating complexity. Reaching global markets.
Turning your product vision into a focused, achievable path to market.
Drug and Device Development
Expert development support to move your product confidently through each stage.
Clinical Development Services
Clinical Trial Services
The clinical expertise and execution to move your development program forward.
Clinical Trial Preparation
Getting your study strategy, design and approvals right from the start.
Clinical Trial Operations
Keeping your clinical trial on track, compliant and moving forward.
Risk Management
RMP development, writing and review of technical protocols and reports.
Registration Pathways
Orbis / ACCESS / Orphan / Provisional / Priority and other expedited pathways.
QMS System Design
Comprehensive audits covering GMP / GLP / GCP / GDP / ISO9001 / ISO13485.
Data Analytics
Understanding and managing your data and biostatistics.
Learn More About Us
We’re a team of down-to-earth, curious and engaged people who genuinely enjoy what we do. We work collaboratively, support one another and bring that same energy, openness and commitment to our clients.
Latest Insights
Insights • Articles • Industry News • Regulatory Updates
Stay informed with the latest regulatory developments, industry trends and emerging issues shaping healthcare product development and commercialisation across Australia, New Zealand and international markets.
Dementia Research in 2026
From Amyloid to Precision Neurodegeneration Adjutor Group | Scientific & Industry Perspective Each year, World Alzheimer’s Day highlights the growing global impact of dementia and the urgent need for better approaches to prevention, diagnosis and treatment. While dementia remains one of the greatest healthcare challenges of our time, 2026 marks a pivotal point in its…
Regulation of In Vivo CAR‑T Therapies
Emerging Regulatory Frameworks for Programmable Immune Engineering Introduction In vivo CAR‑T therapy represents one of the most scientifically disruptive developments in modern biotechnology. Unlike traditional CAR‑T therapies, where T cells are removed from the patient, genetically engineered ex vivo, expanded, and reinfused, in vivo CAR‑T platforms aim to genetically program immune cells directly inside the…
From Sequential to Strategic
How Smart Biotech Companies Are Winning in Accelerated Global Approval Pathways The global biotechnology regulatory environment is no longer just accelerating, it is fragmenting into a set of strategic choices that materially impact time to market, capital efficiency, and valuation. Companies that actively design multi-market regulatory strategies early are gaining measurable advantages. Those that don’t…
What’s your next milestone?
Wherever you are on the journey to market, our team is ready to help you navigate what comes next.